| Primary information |
|---|
| Hemolytik ID | 2635 |
| PMID | 22837667 |
| YEAR | 2012 |
| SEQUENCE | KWKSFLkTFKSLKKTVLHTLLKAISS |
| LENGTH | 26 |
| NAME | K7D |
| C-ter Modification | Amidation |
| N-ter Modification | Acetylation |
| Linear/Cyclic | Linear |
| Stereochemistry | Mix (Contains both L and D amino acids) |
| Modified Residues | None |
| FUNCTION | Anticancer |
| ACTIVITY | MHC =10.4±0.04μmol/L |
| RBCs SOURCE | Human |
| Secondary information |
|---|
| Properties | Physico-Chemical details |
| STRUCTURE | |
| DSSP states | CCGGGHHHHHHHTTSHHHHHHHHHCC |
| SMILES | N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c(C)c1CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1[nH]cnc1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O |
| External Links |
|---|
| PDB exact | PDB partial | SP exact | SP partial | TrEMBL exact | TrEMBL partial | IEDB exact | IEDB partial |
| NA |
NA |
NA |
NA |
NA |
NA |
NA |
NA |
|
| Reference Informaiton |
|---|
| ARTICLE | Role of helicity on the anticancer mechanism of action of cationic-helical peptides. |
| AUTHORS | Huang YB,He LY,Jiang HY |
| JOURNAL | Int J Mol Sci. 2012;13(6):6849-62. doi: 10.3390/ijms13066849. Epub 2012 Jun 5. |